News Website

Comparing Pain Relief in Endometriosis Treatments Amid Pandemic - Physician's Weekly

Comparing Pain Relief in Endometriosis Treatments Amid Pandemic Physician's Weekly

Published: Dec. 12, 2024, 11:22 a.m.

Read Full Article

How health insurance cover can help mainstream IVF treatment - India Today

How health insurance cover can help mainstream IVF treatment India Today

Published: Dec. 10, 2024, 10:40 a.m.

Read Full Article

GSK Korea expands indication for Jemperli in endometrial cancer treatment - KBR

GSK Korea expands indication for Jemperli in endometrial cancer treatment KBR

Published: Dec. 10, 2024, 3:13 a.m.

Read Full Article

Endometriosis Treatment Market Projected to Reach $3.1 Billion by 2034: Advancements in Surgery and Fertility Therapies Fuel Growth - PharmiWeb.com

Endometriosis Treatment Market Projected to Reach $3.1 Billion by 2034: Advancements in Surgery and Fertility Therapies Fuel Growth PharmiWeb.com

Published: Dec. 9, 2024, 10 p.m.

Read Full Article

The Targeted Pulse: Don’t Miss the FDA’s Latest Treatment Decisions and What a Retrospective Study Revealed in Endometrial Cancer - Targeted Oncology

The Targeted Pulse: Don’t Miss the FDA’s Latest Treatment Decisions and What a Retrospective Study Revealed in Endometrial Cancer Targeted Oncology

Published: Dec. 8, 2024, 5 p.m.

Read Full Article

Mental health, endometriosis treatment behind a spike in young people taking up private health insurance - MSN

Mental health, endometriosis treatment behind a spike in young people taking up private health insurance MSN

Published: Dec. 7, 2024, 12:17 a.m.

Read Full Article

Florida Cancer Specialists & Research Institute Case Study Demonstrates Value of Genomic Testing To Improve Treatment and Outcomes For Patients With Inherited Cancers - The Malaysian Reserve

Florida Cancer Specialists & Research Institute Case Study Demonstrates Value of Genomic Testing To Improve Treatment and Outcomes For Patients With Inherited Cancers The Malaysian Reserve

Published: Dec. 6, 2024, 4:44 p.m.

Read Full Article

Estetrol drospirenone effective as firstline endometriosis treatment: Study - Medical Dialogues

Estetrol drospirenone effective as firstline endometriosis treatment: Study Medical Dialogues

Published: Dec. 6, 2024, 1:30 p.m.

Read Full Article

Nova Scotia becomes first province to publicly reimburse JEMPERLI for the treatment of patients with advanced or recurrent dMMR/MSI-H endometrial cancer - BioSpace

Nova Scotia becomes first province to publicly reimburse JEMPERLI for the treatment of patients with advanced or recurrent dMMR/MSI-H endometrial cancer BioSpace

Published: Dec. 6, 2024, 8:22 a.m.

Read Full Article

Nova Scotia becomes first province to publicly reimburse JEMPERLI for the treatment of patients with advanced or recurrent dMMR/MSI-H endometrial cancer - The Malaysian Reserve

Nova Scotia becomes first province to publicly reimburse JEMPERLI for the treatment of patients with advanced or recurrent dMMR/MSI-H endometrial cancer The Malaysian Reserve

Published: Dec. 5, 2024, 3:36 p.m.

Read Full Article

Latest Articles

Comparing Pain Relief in Endometriosis Treatments Amid Pandemic - Physician's Weekly

How health insurance cover can help mainstream IVF treatment - India Today

GSK Korea expands indication for Jemperli in endometrial cancer treatment - KBR

Endometriosis Treatment Market Projected to Reach $3.1 Billion by 2034: Advancements in Surgery and Fertility Therapies Fuel Growth - PharmiWeb.com

The Targeted Pulse: Don’t Miss the FDA’s Latest Treatment Decisions and What a Retrospective Study Revealed in Endometrial Cancer - Targeted Oncology

Mental health, endometriosis treatment behind a spike in young people taking up private health insurance - MSN

Florida Cancer Specialists & Research Institute Case Study Demonstrates Value of Genomic Testing To Improve Treatment and Outcomes For Patients With Inherited Cancers - The Malaysian Reserve

Estetrol drospirenone effective as firstline endometriosis treatment: Study - Medical Dialogues

Nova Scotia becomes first province to publicly reimburse JEMPERLI for the treatment of patients with advanced or recurrent dMMR/MSI-H endometrial cancer - BioSpace

Nova Scotia becomes first province to publicly reimburse JEMPERLI for the treatment of patients with advanced or recurrent dMMR/MSI-H endometrial cancer - The Malaysian Reserve

Subscribe to Our Newsletter